Tradestie Institutional Equity Comparison Engine

GNPX vs NVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NVS Overall Edge

NVS Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GNPX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NVS at 15.2x Forward P/E and 34.0% operating margin (+4.7% YoY). In options structure, GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NVS
GNPX N/M vs NVS 15.2x Fwd P/E
Growth & Margin Winner NVS
Op Margin 0.0% vs 34.0% ยท YoY +0.0% vs +4.7%
Momentum & Technical Winner NVS
1Y -56.6% vs +18.2% ยท 52W Pos 11% vs 58%
Options & Structure Winner NVS
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (6th %ile IV)
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$150.47
-0.5% 1D
Market Cap $285.6B
1M Return -3.71%
1Y Return +18.19%
Forward P/E 15.2x
Unified AI Score
37.0 / 100 SELL
Tech 20.0 Fund 34.0 Flow 50.0 Mom 36.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNPX -56.59% NVS +18.19% Spread: +74.78 pp (NVS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNPX TTM Op. Margin: 0.0% NVS TTM Op. Margin: 34.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNPX vs NVS. Trailing 12-month operating profitability (GNPX 0.0% vs NVS 34.0%) and valuation multiples (GNPX N/M vs NVS 15.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNPX (1) vs NVS (9)
Institutional Metric GNPX NVS Criterion Row Winner
Market Capitalization Scale $2.2M $285.6B Larger Scale NVS
Trailing P/E Ratio Valuation N/M 28.9x Lower Multiple NVS
Forward P/E Ratio Valuation N/M 15.2x Lower Multiple NVS
Revenue Growth (YoY) Growth +0.0% +4.7% Higher Growth NVS
Operating Margin (TTM) Profitability 0.0% 34.0% Higher Margin NVS
Net Profit Margin Profitability 0.0% 17.5% Higher Margin NVS
Return on Equity (ROE) Capital Efficiency -233.7% 24.3% Higher ROE NVS
52-Week Range Position Momentum 11% ($0โ€“$10) 58% ($123โ€“$170) Stronger Trend NVS
Beta / 30D Volatility Risk Regime -4.68ฮฒ ยท 96% Vol 0.32ฮฒ ยท 28% Vol Lower Realized Risk NVS
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 37.0 / 100 (SELL) Higher Composite GNPX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNPX vs NVS Buy Guide
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNPX nor NVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.